Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Infect Genet Evol. 2017 Apr 6;51:194–197. doi: 10.1016/j.meegid.2017.04.004

Table 1.

Subject information.

Subject ID HIV status Primary disease Secondary disease cART NADIR CD4 Last plasma CD4 Last plasma VL
AM AIDS AIDS lymphoma Hodgkin's disease No NKc NK NK
IV AIDS lymphoma Pneumonia NK NK NK
CX HAD none NK NK NK
HCK1 MACa/PCPb/Wasting Kaposi's sarcoma NK 5 NK
HCK2 AIDS lymphoma Kaposi's sarcoma NK NK NK
HCK3 Kaposi's sarcoma None NK NK NK
BW AIDS lymphoma Dementia Unknown adherence NK 4 NK
AZ Atherosclerosis Polypharmacy NK 110 8020
GA HAD Atherosclerosis/PCP 50 <299 NK
DY HAD MAC 2 NK 7,180,000
HC02 HIV+ Plasmacytoma HAND Yes 20 20 <40
HC03 Anal carcinoma Hodgkin's disease 21 21 <40
HC05 Prostate cancer Anal carcinoma 58 154 <40
HC08 Lung cancer None 17 112 <40
HC09 Alzheimer's Atherosclerosis 220 268 <40
a

MAC = Mycobacterium avian complex.

b

PCP = pneumocystis pneumonia.

c

NK = not known.